IDEAS home Printed from https://ideas.repec.org/a/epw/ejmed0/v2y2020i5id40482.html

Nanomedicine and Immunotherapy for Cancers

Author

Listed:
  • A. A. Navas

    (National University of Science and Technology, Sultanate of Oman)

  • N. Doreswamy

    (National Coalition of Independent Scholars, Australia)

  • P. J. Joseph Francis

    (National University of Science and Technology, Sultanate of Oman)

Abstract

Nanomedicine contributes to cancer therapeutics in several ways, harnessing some of the remarkable properties of nanomaterials to target tumor cells with increasing specificity. Nano-scale therapeutic strategies enable the simultaneous transport of hydrophilic and hydrophobic drugs across physical and physiological barriers like the blood-brain barrier. Alternative routes of drug administration, such as the intranasal route, have become viable, with more promising therapies for highly lethal tumors like glioblastomas. Cancer nanomedicine allows increased solubility and bioavailability of anti-cancer drugs, reducing their toxicity. Multi-drug delivery systems such as dendrimers, noble metal nanoparticle drug delivery systems, nanoparticle-based theranostics, and nano-biomarkers may well bring about a sea change in cancer therapeutics. This review presents an overview of the scope of cancer nanomedicine, including immunotherapy for cancer.

Suggested Citation

  • A. A. Navas & N. Doreswamy & P. J. Joseph Francis, 2020. "Nanomedicine and Immunotherapy for Cancers," European Journal of Medical and Health Sciences, European Open Science, vol. 2(5), September.
    • Handle: RePEc:epw:ejmed0:v:2:y:2020:i:5:id:40482
    DOI: 10.24018/ejmed.2020.2.5.482
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejmed/article/view/40482
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejmed/article/download/40482/9037
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejmed.2020.2.5.482?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:2:y:2020:i:5:id:40482. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.